Cargando…

LRRK2 as a Potential Genetic Modifier of Synucleinopathies: Interlacing the Two Major Genetic Factors of Parkinson's Disease

Parkinson's disease (PD) and related Lewy body diseases are characterized by deposition of α-synuclein aggregates in both the central nervous system and peripheral nervous system. Synucleinopathy lesions spread to larger brain areas as the disease progresses, and prion-like cell-to-cell transmi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hyun, Cheol Hwan, Yoon, Chae Young, Lee, He-Jin, Lee, Seung-Jae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Brain and Neural Science 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897686/ https://www.ncbi.nlm.nih.gov/pubmed/24465140 http://dx.doi.org/10.5607/en.2013.22.4.249

Ejemplares similares

Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variants
por: Yang, Jing, et al.
Publicado: (2021)

Genetic Learning Particle Swarm Optimization with Interlaced Ring Topology
por: Borowska, Bożena
Publicado: (2020)

Genetic Variants of LRRK2 in Taiwanese Parkinson’s Disease
por: Wu, Yih-Ru, et al.
Publicado: (2013)

Pool boiling of nanoparticle-modified surface with interlaced wettability
por: Hsu, Chin-Chi, et al.
Publicado: (2012)

On interlaced injector synchrotrons
por: Hardt, W
Publicado: (1966)

An introduction to random interlacements
por: Drewitz, Alexander, et al.
Publicado: (2014)

Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson’s disease
por: Brown, Emmeline E., et al.
Publicado: (2021)

Genetic deletion of nitric oxide synthase 2 ameliorates Parkinson’s disease pathology and neuroinflammation in a transgenic mouse model of synucleinopathy
por: Kim, Jieun, et al.
Publicado: (2023)

Genetic and Environmental Factors Influence the Pleomorphy of LRRK2 Parkinsonism
por: Chittoor-Vinod, Vinita G., et al.
Publicado: (2021)

LRRK2 and Parkinson's disease: from genetics to targeted therapy
por: Sosero, Yuri L., et al.
Publicado: (2023)

Low-temperature synthesis of CuO-interlaced nanodiscs for lithium ion battery electrodes
por: Seo, Seung-Deok, et al.
Publicado: (2011)

Implications of Spectral Interlacing for Quantum Graphs
por: Lu, Junjie, et al.
Publicado: (2023)

High LRRK2 Levels Fail to Induce or Exacerbate Neuronal Alpha-Synucleinopathy in Mouse Brain
por: Herzig, Martin C., et al.
Publicado: (2012)

Interlaced Energy Linac with Smooth Energy Regulation
por: Wronka, Sławomir
Publicado: (2016)

Interlaced X-ray diffraction computed tomography
por: Vamvakeros, Antonios, et al.
Publicado: (2016)

Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease
por: Smith, Laura J., et al.
Publicado: (2022)

Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease
por: Lai, Dongbing, et al.
Publicado: (2021)

Inflammation promotes synucleinopathy propagation
por: Kim, Tae-Kyung, et al.
Publicado: (2022)

Determinantal Structures in Space-Inhomogeneous Dynamics on Interlacing Arrays
por: Assiotis, Theodoros
Publicado: (2020)

On (Non-)Monotonicity and Phase Diagram of Finitary Random Interlacement
por: Cai, Zhenhao, et al.
Publicado: (2021)

Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
por: Lai, Thuy Thi, et al.
Publicado: (2022)

Genetic Analysis of LRRK2 R1628P in Parkinson's Disease in Asian Populations
por: Zhang, Yuan, et al.
Publicado: (2017)

Homozygous mutation of the LRRK2 ROC domain as a novel genetic model of parkinsonism
por: Chen, Meng-Ling, et al.
Publicado: (2022)

Glucocerebrosidase Involvement in Parkinson Disease and Other Synucleinopathies
por: Almeida, Maria do Rosário
Publicado: (2012)

An Enriched Environment Ameliorates Oxidative Stress and Olfactory Dysfunction in Parkinson’s Disease with α-Synucleinopathy
por: Wi, Soohyun, et al.
Publicado: (2018)

LRRK2 at the Crossroad of Aging and Parkinson’s Disease
por: Hur, Eun-Mi, et al.
Publicado: (2021)

Pathological Functions of LRRK2 in Parkinson’s Disease
por: Jeong, Ga Ram, et al.
Publicado: (2020)

Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies
por: Sekiyama, Kazunari, et al.
Publicado: (2012)

From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2
por: Mancini, Andrea, et al.
Publicado: (2020)

The First Interlaced Continuum Robot, Devised to Intrinsically Follow the Leader
por: Kang, Byungjeon, et al.
Publicado: (2016)

Dark Mode Excitation in Three-Dimensional Interlaced Metallic Meshes
por: Powell, Alexander W., et al.
Publicado: (2021)

Linking the Endoplasmic Reticulum to Parkinson’s Disease and Alpha-Synucleinopathy
por: Colla, Emanuela
Publicado: (2019)

Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2(WD40) Genetic Model of Parkinson’s Disease
por: Casu, Maria Antonietta, et al.
Publicado: (2020)

LRRK2 and membrane trafficking: nexus of Parkinson’s disease
por: Hur, Eun-Mi, et al.
Publicado: (2019)

Models for LRRK2-Linked Parkinsonism
por: Li, Tianxia, et al.
Publicado: (2011)

The role of the LRRK2 gene in Parkinsonism
por: Li, Jie-Qiong, et al.
Publicado: (2014)

LRRK2 and Proteostasis in Parkinson’s Disease
por: Pérez-Carrión, María Dolores, et al.
Publicado: (2022)

Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Video Multiple Watermarking Technique Based on Image Interlacing Using DWT
por: Ibrahim, Mohamed M., et al.
Publicado: (2014)

Senescence and impaired DNA damage responses in alpha-synucleinopathy models
por: Yoon, Ye-Seul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qsadk0906o5svsgkbd1jqp1rrv